Broad Based Companies

Company Announcements

Hitachi High-Technologies reported Life Sciences Segment sales for the year ended March 31 increased 3.1% to ¥96.173 billion ($959.9 million), representing 10.2% of company revenues. Biotechnology-related equipment (including LC and spectrophotometers) accounted for 22% of Segment sales, clinical analyzers represented 66% and other products represented 12%. The company announced it is focusing on LC and LC/MS systems.

PicoQuant GmbH established PicoQuant Photonics North America in Westfield, Massachusetts, in April.

Agilent’s Nucleic Acid Solutions Division secured an exclusive license to Aktiv-Dry’s CAN-BD drying technology for nucleic acid active pharmaceutical ingredients.

PerkinElmer opened an EcoAnalytix application and technical center in Mumbai, India, in May. PerkinElmer India currently employs approximately 170 people.

PerkinElmer announced that Michael L. Battles, vice president and controller, is serving as interim CFO, following the resignation of CFO Jeffrey D. Capello on June 6.

PerkinElmer appointed Chief Scientific Officer Daniel Marshak, PhD, to the additional position of president of Greater China operations in July. PerkinElmer currently employs 1,200 people in China.

In May, Thermo Fisher Scientific promoted Marc N. Casper, president of Analytical Technologies, to the newly created position of chief operating officer.

Thermo Fisher Scientific elected Judy C. Lewent to its Board in May, bringing the number of Board members to 10. She was formerly executive vice president and CFO of Merck & Co.

SII NanoTechnology appointed Susumu Kitano, senior vice president of Seiko Instruments, president and CEO in May.

MDS Analytical Technologies’ revenues rose 53% to $118 million for the second quarter ended April 30 (see IBO 6/15/08). Revenue grew 15% on an organic basis. Molecular Devices’ sales rose 8% to $55 million. Including foreign exchange, Sciex joint-venture sales rose 31% to $15 million and MS end-user revenue rose 6%. The business reported soft demand from pharmaceutical customers.

Fiscal 2008 revenues for Halma’s Health and Analysis Sector rose 15.6% to £134.6 million ($269.3 million) (see IBO 6/30/08) to make up 34% of company revenues. The company noted good growth for Water products in the UK and record revenue and profits for the Photonics businesses and Fluid Technology businesses. The US represented 42% of Sector sales.

In July, photonics firm Dynasil acquired Radiation Monitoring Devices for $20 million in cash and stock.

Sales/Orders of Note

Dalton Pharma Services licensed Thermo Fisher Scientific’s enzyme-based manufacturing process for producing nucleic acid biopolymers for pharmaceutical use.

< | >